The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Roscovitine Targets, Protein Kinases and Pyridoxal Kinase
Open accessAbstract
(R)-Roscovitine (CYC202) is often referred to as a "selective inhibitor of cyclin-dependent kinases." Besides its use as a biological tool in cell cycle, neuronal functions, and apoptosis studies, it is currently evaluated as a potential drug to treat cancers, neurodegenerative diseases, viral infections, and glomerulonephritis. We have investigated the selectivity of (R)-roscovitine using three different methods: 1) testing on a wide panel of purified kinases that, along with previously published data, now reaches 151 kinases; 2) identifying roscovitine-binding proteins from various tissue and cell types following their affinity chromatography purification on immobilized roscovitine; 3) investigating the effects of roscovitine on cells deprived of one of its targets, CDK2. Altogether, the results show that (R)-roscovitine is rather selective for CDKs, in fact most kinases are not affected. However, it binds an unexpected, non-protein kinase target, pyridoxal kinase, the enzyme responsible for phosphorylation and activation of vitamin B6. These results could help in interpreting the cellular actions of (R)-roscovitine but also in guiding the synthesis of more selective roscovitine analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
Vermeulen, K., Van Bockstaele, D. R., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,773
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Self-citationProtein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Pyridoxal Phosphate Enzymes: Mechanistic, Structural, and Evolutionary Considerations
Eliot, A. C., & Kirsch, J. F. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074021 · Cited by 950
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 808
Self-citationExploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Self-citationCyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Prieto, I., Odajima, J., Martín, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 796
De Azevedo, W. F., Leclerc, S., Meijer, L., Havlicek, L., Strnad, M., & Kim, S. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0518a.x · Cited by 729
Self-citationGobom, J., Nordhoff, E., Mirgorodskaya, E., Ekman, R., & Roepstorff, P. (1999) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199902)34:2<105::aid-jms768>3.0.co;2-4 · Cited by 688
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
Self-citationA genomic overview of pyridoxal‐phosphate‐dependent enzymes
Percudani, R., & Peracchi, A. (2003) · EMBO reports · doi:10.1038/sj.embor.embor914 · Cited by 551
Pharmacological inhibitors of cyclin-dependent kinases
Knockaert, M., Greengard, P., & Meijer, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02071-0 · Cited by 537
Self-citationMcClue, S. J., Blake, D., Clarke, R., Cowan, A., Cummings, L., Fischer, P. M., MacKenzie, M., Melville, J., Stewart, K., Wang, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10738 · Cited by 364
Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials
Meijer, L., & Raymond, E. (2003) · ChemInform · doi:10.1002/chin.200336265 · Cited by 362
Self-citationAn efficient proteomics method to identify the cellular targets of protein kinase inhibitors
Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., Salassidis, K., Stein-Gerlach, M., Missio, A., Cotten, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535024100 · Cited by 336
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 319
Mills, P. B., Surtees, R. A. H., Champion, M. P., Beesley, C. E., Dalton, N., Scambler, P. J., Heales, S. J. R., Briddon, A., Scheimberg, I., Hoffmann, G. F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi120 · Cited by 309
The loss of circadian PAR bZip transcription factors results in epilepsy
Gachon, F., Fonjallaz, P., Damiola, F., Gos, P., Kodama, T., Zakany, J., Duboule, D., Petit, B., Tafti, M., & Schibler, U. (2004) · Genes & Development · doi:10.1101/gad.301404 · Cited by 284
Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors
Wang, J., Liu, S., Fu, Y., Wang, J. H., & Lu, Y. (2003) · Nature Neuroscience · doi:10.1038/nn1119 · Cited by 279
Chang, Y.-T., Gray, N. S., Rosania, G. R., Sutherlin, D. P., Kwon, S., Norman, T. C., Sarohia, R., Leost, M., Meijer, L., & Schultz, P. G. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80048-9 · Cited by 268
Self-citationProgress in Cell Cycle Research
(1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7 · Cited by 237
Mechanism of CDK5/p25 Binding by CDK Inhibitors
Mapelli, M., Massimiliano, L., Crovace, C., Seeliger, M. A., Tsai, L.-H., Meijer, L., & Musacchio, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049323m · Cited by 207
Self-citationCellular control of gene expression by T-type cyclin/CDK9 complexes
Garriga, J., & Graña, X. (2004) · Gene · doi:10.1016/j.gene.2004.05.007 · Cited by 172
A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease
Cruz, J. C., & Tsai, L.-H. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.002 · Cited by 170
Intracellular Targets of Paullones
Knockaert, M., Wieking, K., Schmitt, S., Leost, M., Grant, K. M., Mottram, J. C., Kunick, C., & Meijer, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202651200 · Cited by 144
Self-citationSynthesis and Target Identification of Hymenialdisine Analogs
Wan, Y., Hur, W., Cho, C. Y., Liu, Y., Adrian, F. J., Lozach, O., Bach, S., Mayer, T., Fabbro, D., Meijer, L., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.01.015 · Cited by 140
Self-citationDisplay cloning: functional identification of natural product receptors using cDNA-phage display
Sche, P. P., McKenzie, K. M., White, J. D., & Austin, D. J. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80018-6 · Cited by 140
A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors
Becker, F., Murthi, K. K., Smith, C. C., Come, J. H., COSTAROLDAN, N., Kaufmann, C. M., Hanke, U., Degenhart, C., Baumann, S. W., Wallner, W., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.001 · Cited by 139
Pippin, J. W., Qu, Q., Meijer, L., & Shankland, S. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119793 · Cited by 134
Self-citationCdk5, a therapeutic target for Alzheimer's disease?
Tsai, L., Lee, M.-S., & Cruz, J. C. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.019 · Cited by 123
Fischer, P. M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365062 · Cited by 116
Zhang, M., Li, J., Chakrabarty, P., Bu, B., & Vincent, I. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63347-0 · Cited by 110
Brehmer, D., Godl, K., Zech, B., Wissing, J. B., & Daub, H. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300139-mcp200 · Cited by 106
Bioluminescent imaging of Cdk2 inhibition in vivo
Zhang, G.-J., Safran, M., Wei, W., Sorensen, E. J., Lassota, P., Zhelev, N., Neuberg, D. S., Shapiro, G. I., & Kaelin, W. G. (2004) · Nature Medicine · doi:10.1038/nm1047 · Cited by 90
Crystal Structure of Brain Pyridoxal Kinase, a Novel Member of the Ribokinase Superfamily
Li, M., Kwok, F., Chang, W., Lau, C.-K., Zhang, J., Lo, S. C., Jiang, T., & Liang, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208600200 · Cited by 90
Self-citationCrystal Structure of Pyridoxal Kinase in Complex with Roscovitine and Derivatives
Tang, L., Li, M., Cao, P., Wang, F., Chang, W., Bach, S., Reinhardt, J., Ferandin, Y., Galons, H., Wan, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500805200 · Cited by 81
Self-citationEffects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication
Schang, L. M. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.024 · Cited by 78
p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol
Knockaert, M., Lenormand, P., Gray, N. S., Schultz, P. G., Pouysségur, J., & Meijer, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205908 · Cited by 64
Self-citationChemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor
Kung, C. K.-H., Kenski, D. M., Dickerson, S. H., Howson, R. W., Kuyper, L. F., Madhani, H. D., & Shokat, K. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407170102 · Cited by 61
Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors
Malumbres, M., Ortega, S., & Barbacid, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.105 · Cited by 56
Pharmacokinetic model of R-roscovitine and its metabolite in healthy male subjects
de la Motte, S., & Gianella-Borradori, A. (2004) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42232 · Cited by 49
Evaluation of Kinase Inhibitor Selectivity by Chemical Proteomics
Daub, H., Godl, K., Brehmer, D., Klebl, B., & Müller, G. (2004) · Assay and Drug Development Technologies · doi:10.1089/154065804323056558 · Cited by 47
CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease
Smith, P. D., O'Hare, M. J., & Park, D. S. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.003 · Cited by 45
Raynaud, F. I., Fischer, P. M., Nutley, B. P., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.353.3.3 · Cited by 44
Haesslein, J., & Jullian, N. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393291 · Cited by 31
Mechanism of H‐8 inhibition of Cyclin‐dependent kinase 9: study using inhibitor‐immobilized matrices
Shima, D., Yugami, M., Tatsuno, M., Wada, T., Yamaguchi, Y., & Handa, H. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00627.x · Cited by 18
Cited by
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Self-citationThe selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Target profiling of small molecules by chemical proteomics
Rix, U., & Superti-Furga, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.216 · Cited by 575
Metadata
- Authors
- Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, M., Coburn, S. P., Tang, L., Jiang, T., Liang, D.-C., Galons, H., Dierick, J.-F., Pinna, L. A., Meggio, F., Totzke, F., Schächtele, C., Lerman, A. S., Carnero, A., Wan, Y., Gray, N., & Meijer, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 35
- Pages
- 31208-31219
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2115346062
- Cited by
- 356
- References
- 52
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.